FDA approved implantable device opens doors for technology within the body

Nucleus 7, a device from Apple and Cochlear, a hearing assistance company, is a surgically implanted sound processor connected to the iPhone to improve the quality of life for impaired patients.

The Nucleus 7 is in a unique position to offer technological care to patients everywhere. The U.S. Food and Drug Administration approved the implant, paving the way for other technologies to push the boundaries of technology within the human body.

“The approval of the Nucleus 7 Sound Processor is a turning point for people with hearing loss, opening the door for them to make phone calls, listen to music in high-quality stereo sound, watch videos and have FaceTime calls streamed directly to their cochlear implant,” Cochlear CEO Chris Smith said in a statement.

Read the full story below:

""
Cara Livernois, News Writer

Cara joined TriMed Media in 2016 and is currently a Senior Writer for Clinical Innovation & Technology. Originating from Detroit, Michigan, she holds a Bachelors in Health Communications from Grand Valley State University.

Around the web

Compensation for heart specialists continues to climb. What does this say about cardiology as a whole? Could private equity's rising influence bring about change? We spoke to MedAxiom CEO Jerry Blackwell, MD, MBA, a veteran cardiologist himself, to learn more.

The American College of Cardiology has shared its perspective on new CMS payment policies, highlighting revenue concerns while providing key details for cardiologists and other cardiology professionals. 

As debate simmers over how best to regulate AI, experts continue to offer guidance on where to start, how to proceed and what to emphasize. A new resource models its recommendations on what its authors call the “SETO Loop.”